NIH Director’s Emergency Transformative Research Awards (R01 Clinical Trial Optional)
This Funding Opportunity Announcement is developed as a Common Fund initiative through the Office of the NIH Director, Office of Strategic Coordination (https://dpcpsi.nih.gov). All NIH Institutes and Centers participate in Common Fund initiatives.
This FOA solicits applications responsive only to the COVID-19 public health emergency through support of the CARES Act.
All other Transformative Research Award applications must be submitted in response to RFA-RM-20-013.
Due to the COVID-19 public health emergency, the Common Fund will dedicate funds provided by the CARES Act to support a total of 5-10 Transformative Research Awards (through this FOA) or [NIH Director’s Emergency] Early Independence Awards* (through RFA-RM-20-021) that bring new, innovative perspectives and approaches to the prevention of, preparation for, or response to coronavirus SARS-CoV-2, domestically or internationally. Any relevant area of coronavirus SARS-CoV-2 research is welcome, including behavioral/social science research, research on health disparities, novel therapeutics, and other related topics. As with all High-Risk, High-Reward Research program applications, innovation may be technological or conceptual.
* Limited to two applications per institution. UIowa applicants must contact the OVPR firstname.lastname@example.org to learn of the limited submissions process at the UI.